首页> 外文期刊>MedChemComm >Molecular localization and characterization of multiple binding sites of organic anion transporting polypeptide 2B1 (OATP2B1) as the mechanism for substrate and modulator dependent drug-drug interaction
【24h】

Molecular localization and characterization of multiple binding sites of organic anion transporting polypeptide 2B1 (OATP2B1) as the mechanism for substrate and modulator dependent drug-drug interaction

机译:分子定位和表征有机阴离子转运多肽2B1(OATP2B1)的多个结合位点作为底物和调节剂依赖性药物相互作用的机制

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Members of the organic anion transporting polypeptide (OATP) transporter family are involved in drug absorption and disposition, and therefore drug-drug and drug-food interactions at these transporters may have both pharmacological and toxicological effects. Accordingly, a detailed understanding of the substrates and modulators, including inhibitors and stimulators, of the transporters, as well as the resulting interactions, is required. However, this is not straightforward, since OATP transporters have multiple binding sites, which exhibit different selectivity for substrates and modulators. Here, we focused on the characterization of the binding sites of OATP2B1, which contributes to the intestinal absorption and hepatic disposition of drugs. Site-directed mutagenesis studies indicated that histidine residues His579 and His618 are involved in the low-and high-affinity sites for estrone-3-sulfate (E(1)3S) transport, respectively. Uptakes of pravastatin, rosuvastatin and sulfasalazine were decreased by mutations of His579 and His618 of OATP2B1, whereas uptakes of fexofenadine and prostaglandin E-2 were not affected. Naringin, an OATP inhibitor, reduced the uptakes of pravastatin, rosuvastatin, sulfasalazine and low-concentration E(1)3S, but not other substrates. In addition, progesterone stimulated the uptake of low-concentration E(1)3S but did not affect or even decreased the uptakes of other substrates. These observations confirm that multiple binding sites are present on OATP2B1, resulting in differential characteristics in the recognition of substrates and modulators. Accordingly, identification of the locations of binding sites on OATP2B1 and their detailed characterization will be necessary to improve the prediction of drug-drug and drug-food interactions on OATP2B1.
机译:有机阴离子转运多肽(OATP)转运蛋白家族的成员参与药物的吸收和处置,因此在这些转运蛋白上的药物-药物相互作用和药物-食物相互作用可能同时具有药理作用和毒理学作用。因此,需要对转运蛋白的底物和调节剂,包括抑制剂和刺激剂,以及由此产生的相互作用的详细理解。然而,这并非一帆风顺,因为OATP转运蛋白具有多个结合位点,这些结合位点对底物和调节剂表现出不同的选择性。在这里,我们集中于OATP2B1的结合位点的表征,这有助于药物的肠道吸收和肝脏处置。定点诱变研究表明,组氨酸残基His579和His618分别参与了雌激素-3-硫酸盐(E(1)3S)运输的低亲和力和高亲和力位点。 OATP2B1的His579和His618突变可降低普伐他汀,瑞舒伐他汀和柳氮磺吡啶的摄取,而非索非那定和前列腺素E-2的摄取不受影响。 Naringin是OATP抑制剂,可降低普伐他汀,瑞舒伐他汀,柳氮磺吡啶和低浓度E(1)3S的摄取,但不降低其他底物的摄取。此外,孕酮刺激了低浓度E(1)3S的吸收,但没有影响甚至没有降低其他底物的吸收。这些观察结果证实OATP2B1上存在多个结合位点,从而导致在识别底物和调节剂方面存在差异。因此,鉴定OATP2B1上结合位点的位置及其详细表征对于提高对OATP2B1上的药物-药物和药物-食物相互作用的预测是必要的。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号